Desi medical devices firms expand footprint, lock horns with global giants

More than half of Transasia Bio-Medicals' sales of Rs 12 billion come from global markets

Transasia Bio-Medicals, which controls over a third of the Indian market in blood analyser machines and attendant chemicals, is making a big push to extend its footprint abroad. Already, more than half of its sales of Rs 12 billion come from global markets. In the last few years, Transasia has bought 14 medium-sized medical technology companies in various countries, including the US, Russia and Turkey, to cater to those markets. 

Suresh Vazirani, managing director, Transasia Bio-Medicals, says there are two reasons for the strategy. First, some of these companies have specialised technology not available in India. Second, it is often